These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23257459)

  • 1. [Detection of JAK2V617F mutation rate by real-time fluorescent quantitative PCR using allele specific primer and TaqMan-MGB probe for dual inhibiting amplification of wild type alleles].
    Liang GW; Shao DH; He ML; Cao QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1486-91. PubMed ID: 23257459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of JAK2V617F mutation in patients with myeloproliferative disorders with TaqMan-MGB probe].
    Ruan GR; Chen SS; Li LD; Liu YR; Qin YZ; Li JL; Ma X; Wang FR; Jiang Q; Jiang B; Liu KY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2401-4. PubMed ID: 18036317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A novel modi cation of real-time AS-qPCR by using locked nucleic acid-modified oligonucleotide probe as wild type allele amplification blockers for quantitative detection of the JAK2 V617F mutation].
    Shao DH; Liang GW; He ML; Cao QY
    Zhonghua Xue Ye Xue Za Zhi; 2013 May; 34(5):421-5. PubMed ID: 23688754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melting curve analysis after T allele enrichment (MelcaTle) as a highly sensitive and reliable method for detecting the JAK2V617F mutation.
    Morishita S; Takahashi K; Araki M; Hironaka Y; Sunami Y; Edahiro Y; Tsutsui M; Ohsaka A; Tsuneda S; Komatsu N
    PLoS One; 2015; 10(3):e0122003. PubMed ID: 25794279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2V617F allele burden in patients with myeloproliferative neoplasms.
    Alshemmari SH; Rajaan R; Ameen R; Al-Drees MA; Almosailleakh MR
    Ann Hematol; 2014 May; 93(5):791-6. PubMed ID: 24362471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms.
    Hu L; Pu L; Ding Y; Li M; Cabanero M; Xie J; Zhou D; Yang D; Zhang C; Wang H; Zhai Z; Ru X; Li J; Xiong S
    Hematology; 2017 Jul; 22(6):354-360. PubMed ID: 27976991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive detection and quantification of the JAK2V617F allele by real-time PCR blocking wild-type amplification by using a peptide nucleic acid oligonucleotide.
    Huijsmans CJ; Poodt J; Savelkoul PH; Hermans MH
    J Mol Diagn; 2011 Sep; 13(5):558-64. PubMed ID: 21723417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-round allele specific-polymerase chain reaction: a simple and highly sensitive method for JAK2V617F mutation detection.
    Kannim S; Thongnoppakhun W; Auewarakul CU
    Clin Chim Acta; 2009 Mar; 401(1-2):148-51. PubMed ID: 19135044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms.
    Minnucci G; Amicarelli G; Salmoiraghi S; Spinelli O; Guinea Montalvo ML; Giussani U; Adlerstein D; Rambaldi A
    Haematologica; 2012 Sep; 97(9):1394-400. PubMed ID: 22315499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative competitive allele-specific TaqMan duplex PCR (qCAST-Duplex PCR) assay: a refined method for highly sensitive and specific detection of
    Hsu CC; Huang CE; Wu YY; Chen YY; Lung J; Leu YW; Li CP; Tsou HY; Chuang WH; Lu CH; Chen CC
    Haematologica; 2018 Oct; 103(10):e450-e454. PubMed ID: 29748437
    [No Abstract]   [Full Text] [Related]  

  • 11. Fully automated and super-rapid system for the detection of JAK2V617F mutation.
    Tanaka R; Kuroda J; Stevenson W; Ashihara E; Ishikawa T; Taki T; Kobayashi Y; Kamitsuji Y; Kawata E; Takeuchi M; Murotani Y; Yokota A; Hirai M; Majima S; Taniwaki M; Maekawa T; Kimura S
    Leuk Res; 2008 Sep; 32(9):1462-7. PubMed ID: 18328559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [JAK2V617F mutation and TNF-α expression in myeloproliferative neoplasms and their correlation].
    Sun CC; Li Y; Tian WJ; Chen YJ; Zhang LY; Liu X; Shan NN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1022-6. PubMed ID: 25130821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical implication of JAK2 mutation expression in patients with myeloproliferative disorders].
    Fei HR; Zhang R; Chen SN; Pan JL; Cen JN; Xue YQ
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):271-3. PubMed ID: 17637260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.
    Denys B; El Housni H; Nollet F; Verhasselt B; Philippé J
    J Mol Diagn; 2010 Jul; 12(4):512-9. PubMed ID: 20431031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between TET2 Gene SNP rs3733609 C/T and JAK2V617F Allele Burden in Patients with Myeloproliferative Neoplasms].
    Xiao X; Liu XL; Shen XH; Deng MY; Liu SF; Zhang GS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1574-1579. PubMed ID: 31607314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
    Zhu JF; Liu Y; Liu P; Jia MF; Cheng J; Zhao L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):916-20. PubMed ID: 21867614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].
    Chae H; Lee JH; Lim J; Jung SW; Kim M; Kim Y; Han K; Cho BS; Cho SG; Lee JW; Min WS
    Korean J Lab Med; 2009 Jun; 29(3):243-8. PubMed ID: 19571623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The quantitative assay and clinical significance of JAK2V617F mutation in 131 patients with chronic myeloproliferative disorders].
    Shen YM; Chao HY; Zhang R; Feng YF; Cen JN; Yao L; Shen HJ; Zhu ZL; Xue YQ
    Zhonghua Nei Ke Za Zhi; 2009 Feb; 48(2):140-3. PubMed ID: 19549471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease.
    Huijsmans CJ; Poodt J; Damen J; van der Linden JC; Savelkoul PH; Pruijt JF; Hilbink M; Hermans MH
    PLoS One; 2012; 7(7):e38362. PubMed ID: 22768290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [JAK2V617F mutation and p-STAT5 protein expression in peripheral blood cells of patients with myeloproliferative neoplasm and their relations with clinical features].
    Chen YX; Li Y; Zhang LY; Liu X; Shan NN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1398-404. PubMed ID: 23257441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.